Previous Article | Next Article 
Journal of Virology, January 2007, p. 237-247, Vol. 81, No. 1
0022-538X/07/$08.00+0 doi:10.1128/JVI.01590-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Differential Induction of Type I Interferon Responses in Myeloid Dendritic Cells by Mosquito and Mammalian-Cell-Derived Alphaviruses
Reed S. Shabman,1,2,3
Thomas E. Morrison,1,2,3
Christopher Moore,4
Laura White,2,3
Mehul S. Suthar,1,2,3
Linda Hueston,5
Nestor Rulli,5
Brett Lidbury,5
Jenny P.-Y. Ting,4
Suresh Mahalingam,5 and
Mark T. Heise1,2,3*
Department of Genetics,1
Department of Microbiology and Immunology,2
The Carolina Vaccine Institute,3
The Lineberger Comprehensive Cancer Center, University of North CarolinaChapel Hill, Chapel Hill, North Carolina 27599,4
University of Canberra, Canberra, Australia5
Received 25 July 2006/
Accepted 10 October 2006
Dendritic cells (DCs) are an important early target cell for many mosquito-borne viruses, and in many cases mosquito-cell-derived arboviruses more efficiently infect DCs than viruses derived from mammalian cells. However, whether mosquito-cell-derived viruses differ from mammalian-cell-derived viruses in their ability to induce antiviral responses in the infected dendritic cell has not been evaluated. In this report, alphaviruses, which are mosquito-borne viruses that cause diseases ranging from encephalitis to arthritis, were used to determine whether viruses grown in mosquito cells differed from mammalian-cell-derived viruses in their ability to induce type I interferon (IFN) responses in infected primary dendritic cells. Consistent with previous results, mosquito-cell-derived Ross River virus (mos-RRV) and Venezuelan equine encephalitis virus (mos-VEE) exhibited enhanced infection of primary myeloid dendritic cells (mDCs) compared to mammalian-cell-derived virus preparations. However, unlike the mammalian-cell-derived viruses, which induced high levels of type I IFN in the infected mDC cultures, mos-RRV and mos-VEE were poor IFN inducers. Furthermore, the poor IFN induction by mos-RRV contributed to the enhanced infection of mDCs by mos-RRV. These results suggest that the viruses initially delivered by the mosquito vector differ from those generated in subsequent rounds of replication in the host, not just with respect to their ability to infect dendritic cells but also in their ability to induce or inhibit antiviral type I IFN responses. This difference may have an important impact on the mosquito-borne virus's ability to successfully make the transition from the arthropod vector to the vertebrate host.
* Corresponding author. Mailing address: The Carolina Vaccine Institute, The University of North Carolina, Chapel Hill, NC 27599. Phone: (919) 843-1492. Fax: (919) 843-6924. E-mail:
heisem{at}med.unc.edu.
Published ahead of print on 1 November 2006.
Journal of Virology, January 2007, p. 237-247, Vol. 81, No. 1
0022-538X/07/$08.00+0 doi:10.1128/JVI.01590-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Konopka, J. L., Thompson, J. M., Whitmore, A. C., Webb, D. L., Johnston, R. E.
(2009). Acute Infection with Venezuelan Equine Encephalitis Virus Replicon Particles Catalyzes a Systemic Antiviral State and Protects from Lethal Virus Challenge. J. Virol.
83: 12432-12442
[Abstract]
[Full Text]
-
Souza-Neto, J. A., Sim, S., Dimopoulos, G.
(2009). An evolutionary conserved function of the JAK-STAT pathway in anti-dengue defense. Proc. Natl. Acad. Sci. USA
106: 17841-17846
[Abstract]
[Full Text]
-
Simmons, J. D., White, L. J., Morrison, T. E., Montgomery, S. A., Whitmore, A. C., Johnston, R. E., Heise, M. T.
(2009). Venezuelan Equine Encephalitis Virus Disrupts STAT1 Signaling by Distinct Mechanisms Independent of Host Shutoff. J. Virol.
83: 10571-10581
[Abstract]
[Full Text]
-
Frieman, M., Ratia, K., Johnston, R. E., Mesecar, A. D., Baric, R. S.
(2009). Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-{kappa}B Signaling. J. Virol.
83: 6689-6705
[Abstract]
[Full Text]
-
Shabman, R. S., Rogers, K. M., Heise, M. T.
(2008). Ross River Virus Envelope Glycans Contribute to Type I Interferon Production in Myeloid Dendritic Cells. J. Virol.
82: 12374-12383
[Abstract]
[Full Text]
-
Daffis, S., Samuel, M. A., Suthar, M. S., Gale, M. Jr., Diamond, M. S.
(2008). Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection. J. Virol.
82: 10349-10358
[Abstract]
[Full Text]
-
Coffey, L. L., Vasilakis, N., Brault, A. C., Powers, A. M., Tripet, F., Weaver, S. C.
(2008). Arbovirus evolution in vivo is constrained by host alternation. Proc. Natl. Acad. Sci. USA
105: 6970-6975
[Abstract]
[Full Text]
-
Randall, R. E., Goodbourn, S.
(2008). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol.
89: 1-47
[Abstract]
[Full Text]
-
Silva, M. C., Guerrero-Plata, A., Gilfoy, F. D., Garofalo, R. P., Mason, P. W.
(2007). Differential Activation of Human Monocyte-Derived and Plasmacytoid Dendritic Cells by West Nile Virus Generated in Different Host Cells. J. Virol.
81: 13640-13648
[Abstract]
[Full Text]
-
Arjona, A., Ledizet, M., Anthony, K., Bonafe, N., Modis, Y., Town, T., Fikrig, E.
(2007). West Nile Virus Envelope Protein Inhibits dsRNA-Induced Innate Immune Responses. J. Immunol.
179: 8403-8409
[Abstract]
[Full Text]
-
Frieman, M., Yount, B., Heise, M., Kopecky-Bromberg, S. A., Palese, P., Baric, R. S.
(2007). Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum/Golgi Membrane. J. Virol.
81: 9812-9824
[Abstract]
[Full Text]
-
Durso, R. J., Andjelic, S., Gardner, J. P., Margitich, D. J., Donovan, G. P., Arrigale, R. R., Wang, X., Maughan, M. F., Talarico, T. L., Olmsted, R. A., Heston, W. D.W., Maddon, P. J., Olson, W. C.
(2007). A Novel Alphavirus Vaccine Encoding Prostate-Specific Membrane Antigen Elicits Potent Cellular and Humoral Immune Responses. Clin. Cancer Res.
13: 3999-4008
[Abstract]
[Full Text]